Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Dechra Pharmaceuticals PLC
  6. News
  7. Summary
    DPH   GB0009633180

DECHRA PHARMACEUTICALS PLC

(DPH)
  Report
Real-time Estimate Cboe Europe  -  05/17 04:32:00 am EDT
3294.00 GBX   +0.30%
04/26Jefferies Reduces Dechra Pharmaceuticals PT, Keeps Hold Rating
MT
04/08FTSE 100 Closes Higher Led by Mining, Energy Stocks
DJ
03/03DECHRA PHARMACEUTICALS PLC : Ex-dividend day for interim dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Dechra Pharmaceuticals to Appoint New Chairman in January 2022

11/19/2021 | 02:47am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
DECHRA PHARMACEUTICALS PLC 0.61% 3304 Delayed Quote.-38.33%
ULTRA ELECTRONICS HOLDINGS PLC 0.93% 3258 Delayed Quote.1.51%
ZR (ZR) - CBE (ELECTRONIC)/C1 2.82% 17.86 End-of-day quote.18.73%
All news about DECHRA PHARMACEUTICALS PLC
04/26Jefferies Reduces Dechra Pharmaceuticals PT, Keeps Hold Rating
MT
04/08FTSE 100 Closes Higher Led by Mining, Energy Stocks
DJ
03/03DECHRA PHARMACEUTICALS PLC : Ex-dividend day for interim dividend
FA
02/23WALL STREET STOCK EXCHANGE : Wall Street struggles for direction after cyberattacks
02/23Liberum Lifts Dechra Pharmaceuticals To Hold From Sell
MT
02/23ANALYST RECOMMENDATIONS : Anglo American, BP Plc, Cisco, Intel, Home Depot...
02/22FTSE Russell May Add EasyJet, Drop Dechra Pharmaceuticals From FTSE 100 Index
MT
02/22HSBC Keeps Dechra Pharmaceuticals At Buy, Cuts PT
MT
02/21DECHRA PHARMACEUTICALS : 21 February 2022 Recording of the Analyst Presentation regarding ..
PU
02/21ANALYST RECOMMENDATION : Flutter, Foot Locker, GSK, Nike, On Holding...
More news
Analyst Recommendations on DECHRA PHARMACEUTICALS PLC
More recommendations
Financials
Sales 2022 664 M 813 M 813 M
Net income 2022 77,0 M 94,3 M 94,3 M
Net Debt 2022 162 M 199 M 199 M
P/E ratio 2022 48,3x
Yield 2022 1,34%
Capitalization 3 560 M 4 359 M 4 359 M
EV / Sales 2022 5,60x
EV / Sales 2023 5,08x
Nbr of Employees -
Free-Float 98,6%
Chart DECHRA PHARMACEUTICALS PLC
Duration : Period :
Dechra Pharmaceuticals PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DECHRA PHARMACEUTICALS PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 3 284,00 GBX
Average target price 4 842,70 GBX
Spread / Average Target 47,5%
EPS Revisions
Managers and Directors
Ian David Page Chief Executive Officer & Executive Director
Paul Sandland Chief Financial Officer & Executive Director
Alison Elizabeth Platt Chairman
Susan Longhofer Chief Scientific Officer
Allen Mellor Group Director-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
DECHRA PHARMACEUTICALS PLC-38.33%4 359
ZOETIS-32.25%77 809
ELANCO ANIMAL HEALTH INCORPORATED-21.53%10 558
BLUESTAR ADISSEO COMPANY-23.13%3 710
VIRBAC-17.08%3 095
VIMIAN GROUP AB (PUBL)-28.99%2 182